Certain confidential information obtained in this document, marked by [**], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private...Summit Therapeutics Inc. • August 6th, 2024 • Pharmaceutical preparations
Certain confidential information obtained in this document, marked by [**], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private...Summit Therapeutics Inc. • August 6th, 2024 • Pharmaceutical preparations
Certain confidential information obtained in this document, marked by [**], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private...Summit Therapeutics Inc. • August 6th, 2024 • Pharmaceutical preparations
